Related references
Note: Only part of the references are listed.Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer
Lishuang Qi et al.
BRIEFINGS IN BIOINFORMATICS (2016)
Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer
Constanze Buhrmann et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Test set bias affects reproducibility of gene signatures
Prasad Patil et al.
BIOINFORMATICS (2015)
The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracilresistance in human colon cancer cells
Naruji Kugimiya et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
The consensus molecular subtypes of colorectal cancer
Justin Guinney et al.
NATURE MEDICINE (2015)
MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma
Yong-Qing Tong et al.
ONCOTARGET (2015)
Laminin gene LAMB4 is somatically mutated and expressionally altered in gastric and colorectal cancers
Mi Ryoung Choi et al.
APMIS (2015)
Individual-level analysis of differential expression of genes and pathways for personalized medicine
Hongwei Wang et al.
BIOINFORMATICS (2015)
Gene signatures of drug resistance predict patient survival in colorectal cancer
Y. Zheng et al.
PHARMACOGENOMICS JOURNAL (2015)
Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway
B. Zhang et al.
BRITISH JOURNAL OF CANCER (2014)
Proteomic and Functional Investigation of the Colon Cancer Relapse-Associated Genes NOX4 and ITGA3
Kerry M. Bauer et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Epigenetic Inactivation of the BRCA1 Interactor SRBC and Resistance to Oxaliplatin in Colorectal Cancer
Catia Moutinho et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Molecular Alterations and Biomarkers in Colorectal Cancer
William M. Grady et al.
TOXICOLOGIC PATHOLOGY (2014)
Evaluation of 5-Fluorouracil Metabolic Enzymes as Predictors of Response to Adjuvant Chemotherapy Outcomes in Patients with Stage II/III Colorectal Cancer: A Decision-Curve Analysis
Kohei Shigeta et al.
WORLD JOURNAL OF SURGERY (2014)
Genomic landscape of metastatic colorectal cancer
Josien C. Haan et al.
NATURE COMMUNICATIONS (2014)
A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation
Xianxiao Zhou et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Impact of Bioinformatic Procedures in the Development and Translation of High-Throughput Molecular Classifiers in Oncology
Charles Ferte et al.
CLINICAL CANCER RESEARCH (2013)
Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil-based adjuvant chemotherapy
Maria Dolores Giraldez et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The Clinical Relevance of Cancer Cell Lines
Jean-Pierre Gillet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells
G. Can et al.
ONCOGENE (2013)
An Integrated Approach to Uncover Driver Genes in Breast Cancer Methylation Genomes
Xiaopei Shen et al.
PLOS ONE (2013)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
Reducing confounding and suppression effects in TCGA data: an integrated analysis of chemotherapy response in ovarian cancer
Fang-Han Hsu et al.
BMC GENOMICS (2012)
Identification of Galanin and Its Receptor GalR1 as Novel Determinants of Resistance to Chemotherapy and Potential Biomarkers in Colorectal Cancer
Leanne Stevenson et al.
CLINICAL CANCER RESEARCH (2012)
Adjuvant therapy in colon cancer
Janet S. Graham et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2012)
Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways
Qiang Chen et al.
HEPATOLOGY (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
Can predictive biomarkers in breast cancer guide adjuvant endocrine therapy?
Karin Beelen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
The IntAct molecular interaction database in 2012
Samuel Kerrien et al.
NUCLEIC ACIDS RESEARCH (2012)
KEGG for integration and interpretation of large-scale molecular data sets
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2012)
Multi-Gene Expression Predictors of Single Drug Responses to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance
J. Stuart Ferriss et al.
PLOS ONE (2012)
Molecular Marker Identification for Relapse Prediction in 5-FU-Based Adjuvant Chemotherapy in Gastric and Colorectal Cancers
Kazushige Ishida et al.
PLOS ONE (2012)
Three-gene predictor of clinical outcome for gastric cancer patients treated with chemotherapy
H. K. Kim et al.
PHARMACOGENOMICS JOURNAL (2012)
Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer
Wen Lee Tan et al.
CANCER BIOLOGY & THERAPY (2011)
Smad4 Inactivation Promotes Malignancy and Drug Resistance of Colon Cancer
Panagiotis Papageorgis et al.
CANCER RESEARCH (2011)
Zebrafish Stem Cell Differentiation Stage Factors Suppress Bcl-xL Release and Enhance 5-Fu-Mediated Apoptosis in Colon Cancer Cells
F. D'Anselmi et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Implementing prognostic and predictive biomarkers in CRC clinical trials
Sandra Van Schaeybroeck et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Reactome: a database of reactions, pathways and biological processes
David Croft et al.
NUCLEIC ACIDS RESEARCH (2011)
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients
Hark Kyun Kim et al.
PLOS ONE (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance
Jean-Pierre Gillet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
Microsatellite instability as a marker of prognosis and response to therapy: A meta-analysis of colorectal cancer survival data
Cecilia Guastadisegni et al.
EUROPEAN JOURNAL OF CANCER (2010)
Experimentally Derived Metastasis Gene Expression Profile Predicts Recurrence and Death in Patients With Colon Cancer
J. Joshua Smith et al.
GASTROENTEROLOGY (2010)
Tackling the widespread and critical impact of batch effects in high-throughput data
Jeffrey T. Leek et al.
NATURE REVIEWS GENETICS (2010)
MINT, the molecular interaction database: 2009 update
Arnaud Ceol et al.
NUCLEIC ACIDS RESEARCH (2010)
Relative Expression Analysis for Molecular Cancer Diagnosis and Prognosis
James A. Eddy et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2010)
Human Protein Reference Database-2009 update
T. S. Keshava Prasad et al.
NUCLEIC ACIDS RESEARCH (2009)
Review: Systemic treatment of advanced colorectal cancer: Tailoring therapy to the tumor
John M. Carethers
Therapeutic Advances in Gastroenterology (2008)
Role of IKK and oscillatory NFκB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells
Ryuichi Fukuyama et al.
MOLECULAR CARCINOGENESIS (2007)
Current concepts - Microarray analysis and tumor classification
John Quackenbush
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer
J Boyer et al.
CANCER RESEARCH (2006)
SMAD4 levels and response to 5-fluorouracil in colorectal cancer
P Alhopuro et al.
CLINICAL CANCER RESEARCH (2005)
The MIPS mammalian protein-protein interaction database
P Pagel et al.
BIOINFORMATICS (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Timeline - Chemotherapy and the war on cancer
BA Chabner et al.
NATURE REVIEWS CANCER (2005)
The Biomolecular Interaction Network Database and related tools 2005 update
C Alfarano et al.
NUCLEIC ACIDS RESEARCH (2005)
The Database of Interacting Proteins: 2004 update
L Salwinski et al.
NUCLEIC ACIDS RESEARCH (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Controlling the false discovery rate in behavior genetics research
Y Benjamini et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
T Watanabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
